Iterum Therapeutics Plc
(NASDAQ : ITRM)

( )
ITRM PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 6.89%160.030.0%$1347.19m
AMGNAmgen, Inc. -0.13%249.621.3%$691.62m
NVAXNovavax, Inc. 3.43%201.3480.0%$571.11m
SNSSSunesis Pharmaceuticals, Inc. -1.50%7.880.7%$550.84m
ILMNIllumina, Inc. -1.26%398.073.5%$515.02m
GILDGilead Sciences, Inc. 0.63%65.301.0%$465.35m
REGNRegeneron Pharmaceuticals, Inc. 0.86%481.162.7%$431.65m
VRTXVertex Pharmaceuticals, Inc. 0.55%217.131.9%$373.76m
ALXNAlexion Pharmaceuticals, Inc. 1.02%155.292.0%$316.00m
BIIBBiogen, Inc. -0.15%265.791.7%$265.53m
BNTXBioNTech SE 2.28%132.600.0%$236.33m
EXASEXACT Sciences Corp. -0.67%127.1418.4%$192.79m
NBIXNeurocrine Biosciences, Inc. 2.24%95.054.9%$177.79m
CRSPCRISPR Therapeutics AG 1.85%123.110.6%$176.91m
TWSTTwist Bioscience Corp. 0.87%142.030.0%$150.98m

Company Profile

Iterum Therapeutics Plc is a pharmaceutical company, which engages in the development and commercialization of sulopenem to be potentially the first and only oral and intravenous (IV) branded penem available. The company was founded by Corey N. Fishman on June 24, 2015 and is headquartered in Dublin, Ireland.